Sementis is an Australian unlisted public biotechnology company based in Adelaide, South Australia that is dedicated to the research and development of new vaccines to tackle the world’s most challenging diseases.
The Company’s mission is to deliver an adaptable vaccine platform in response to rapidly emerging diseases of pandemic proportion and also to treat diseases of high unmet medical need including allergies.
